Receptor mediated uptake of peptides that bind the human transferrin receptor.
about
Progress and perspectives on targeting nanoparticles for brain drug delivery.Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.Identification of the Receptor Binding Domain of the Mouse Mammary Tumor Virus Envelope ProteinIdentification using phage display of peptides promoting targeting and internalization into HPV-transformed cell lines.Identification of a Peptide for Systemic Brain Delivery of a Morpholino Oligonucleotide in Mouse Models of Spinal Muscular AtrophyLipid vesicles containing transferrin receptor binding peptide TfR-T12 and octa-arginine conjugate stearyl-R8 efficiently treat brain glioma along with glioma stem cellsIdentification of peptide sequences that target to the brain using in vivo phage display.A novel transferrin receptor-targeted hybrid peptide disintegrates cancer cell membrane to induce rapid killing of cancer cells.Mouse transferrin receptor 1 is the cell entry receptor for mouse mammary tumor virus.In vivo phage display screen for peptide sequences that cross the blood-cerebrospinal-fluid barrier.Transferrin receptor-targeted theranostic gold nanoparticles for photosensitizer delivery in brain tumors.Mechanisms of Dihydroartemisinin and Dihydroartemisinin/Holotransferrin Cytotoxicity in T-Cell Lymphoma Cells.Enhanced anti-ischemic stroke of ZL006 by T7-conjugated PEGylated liposomes drug delivery system.Dual Receptor-Targeted Theranostic Nanoparticles for Localized Delivery and Activation of Photodynamic Therapy Drug in Glioblastomas.An RNA alternative to human transferrin: a new tool for targeting human cells.Phage display as a tool to discover blood-brain barrier (BBB)-shuttle peptides: panning against a human BBB cellular model.Reversible activation of pH-sensitive cell penetrating peptides attached to gold surfacesTargeted delivery across the blood-brain barrier.VDAC1-based peptides: novel pro-apoptotic agents and potential therapeutics for B-cell chronic lymphocytic leukemia.Antisense oligonucleotide-based therapy in human erythropoietic protoporphyria.Nanotherapeutic strategies for the treatment of Alzheimer's disease.Targeted Delivery of siRNA to Transferrin Receptor Overexpressing Tumor Cells via Peptide Modified Polyethylenimine.Blood-brain barrier shuttle peptides: an emerging paradigm for brain delivery.D-Peptides as Recognition Molecules and Therapeutic Agents.A myristoylated cell-penetrating peptide bearing a transferrin receptor-targeting sequence for neuro-targeted siRNA delivery.Immunogenicity and toxicity of transferrin receptor-targeted hybrid peptide as a potent anticancer agent.Design of brain imaging agents for positron emission tomography: do large bioconjugates provide an opportunity for in vivo brain imaging?In vitro and initial in vivo evaluation of (68)Ga-labeled transferrin receptor (TfR) binding peptides as potential carriers for enhanced drug transport into TfR expressing cells.Effect of integrin receptor-targeted liposomal paclitaxel for hepatocellular carcinoma targeting and therapy.Sticky water surfaces: helix-coil transitions suppressed in a cell-penetrating peptide at the air-water interface.Targeting Malignant Brain Tumors with Antibodies.Targeted Delivery of siRNA Therapeutics to Malignant Tumors.Selection and identification of transferrin receptor-specific peptides as recognition probes for cancer cells.Nanoparticle/siRNA-based therapy strategies in glioma: which nanoparticles, which siRNAs?Applying the retro-enantio approach to obtain a peptide capable of overcoming the blood-brain barrier.Acid active receptor-specific peptide ligand for in vivo tumor-targeted delivery.Identification and characterization of highly versatile peptide-vectors that bind non-competitively to the low-density lipoprotein receptor for in vivo targeting and delivery of small molecules and protein cargos.Immunosilencing peptides by stereochemical inversion and sequence reversal: retro-D-peptides.NKp44-Derived Peptide Binds Proliferating Cell Nuclear Antigen and Mediates Tumor Cell Death.Dual-targeting biomimetic delivery for anti-glioma activity via remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy.
P2860
Q26740580-FF598449-5C73-4F58-8264-2FAB0249B48BQ26778701-CD48E9B0-F2C4-4998-8D09-2D0F97ACDF68Q27485665-AC71F250-0244-454F-BC0C-922E33F69116Q31114638-659CBB3D-C6BF-4296-8904-D3B6A413058AQ33786251-94245442-2EC2-48A4-81F3-BB038E214E3FQ33799308-53E88B93-D02A-4ACE-98F2-8FC477732319Q33972613-B00F2E89-FE48-4372-B647-24F93EFCD2C4Q33995305-405CA307-B396-447E-B314-993113162A1FQ34148434-D9AC4DD7-2B94-4230-9D52-EF60273A56CBQ35435425-2C64F4D9-D520-424B-8276-C2190A27F347Q35624123-D5A011A2-8704-4266-86DB-9BA23F150D35Q35821436-16632F3F-7A36-4000-B3A1-367E0223DF44Q35898349-DA6E385E-C781-4DA5-810D-2C24F91F22A0Q36042421-51F16BAC-7B6D-4D42-92D5-48AA89EA8955Q36077849-6FB22649-DBA3-42F3-A9D9-96939240957AQ36093633-8F21326B-A585-4431-A253-D57FC8E77E30Q36169331-5C90F6BC-B61F-45A9-ADF7-CE83F623CFAEQ36316725-EA875B65-0100-4DBE-8575-CC3F71FA165DQ37211985-0D2F62A6-FC3A-47EA-B579-A44F8E76563CQ37693360-2A57CC2E-D78C-49A2-97D4-EDEA9BCE93C0Q38358865-4627D4AA-1FF5-405A-AC67-8AB1EC913328Q38741392-4EFA0E94-F258-42B4-867D-9348BA698108Q38836486-7EDA8F2F-D3D3-43BC-874A-EDF819EEC12DQ38851989-E3419C71-117B-42E4-BF46-DC517EE38B6EQ38862070-CBB81443-683E-4406-98C7-C44206B098C3Q39208816-2212B3E9-5CBA-4286-AC4E-025832DCFEA9Q39348133-A9039F48-4178-405D-98C3-AD404EEDDD21Q39703349-E1CF7C92-75AF-4802-94BD-D23E2D674864Q41110002-6AB3B10E-D1F9-4C50-AEAA-9F22BD984ADAQ41705417-B598366A-69A5-4992-BD51-CE74CB3BEDA6Q42267793-64AD0E4A-7675-46C3-82F4-C8762F9E73A4Q47152520-5DF0C221-81B6-4D8F-8794-F451FE9BC1A4Q47431564-5BA6993F-B1B8-4E13-B1B4-F8F309F07691Q47937284-D6BB466F-2C81-4265-AA03-9974E0889361Q48344384-9345A432-8B63-4870-89F2-AE4F02752E89Q51014889-E7384909-AF77-4A7D-94DB-4FC7ACE56A0FQ51746979-8F355BDD-1901-47A0-B1C5-D9314475E767Q52565478-8204E59D-0F33-4933-B8CC-13EAB76BDA6AQ55020290-A4FB46DE-14C8-40C6-875B-D1EBEA1C1B6DQ55300546-BFF4C77B-F5DF-418C-81A3-16DC96C12726
P2860
Receptor mediated uptake of peptides that bind the human transferrin receptor.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Receptor mediated uptake of peptides that bind the human transferrin receptor.
@en
type
label
Receptor mediated uptake of peptides that bind the human transferrin receptor.
@en
prefLabel
Receptor mediated uptake of peptides that bind the human transferrin receptor.
@en
P2093
P2860
P1433
P1476
Receptor mediated uptake of peptides that bind the human transferrin receptor.
@en
P2093
P2860
P304
P356
10.1046/J.1432-1327.2001.02073.X
P407
P577
2001-04-01T00:00:00Z